BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25063255)

  • 1. Medicare Annual Wellness Visits: patient need and pharmacist patient care services intersect.
    Heaton PC
    J Am Pharm Assoc (2003); 2014; 54(4):336-7. PubMed ID: 25063255
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and implementation of a pharmacist-delivered Medicare annual wellness visit at a family practice office.
    Thomas MH; Goode JV
    J Am Pharm Assoc (2003); 2014; 54(4):427-34. PubMed ID: 25063263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial implications of pharmacist-led Medicare annual wellness visits.
    Park I; Sutherland SE; Ray L; Wilson CG
    J Am Pharm Assoc (2003); 2014; 54(4):435-40. PubMed ID: 25063264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community pharmacist-delivered Medicare Annual Wellness Visits within a family medicine practice.
    Evans TA; Fabel PH; Ziegler B
    J Am Pharm Assoc (2003); 2017; 57(3S):S247-S251. PubMed ID: 28400254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consortium recommendations for advancing pharmacists' patient care services and collaborative practice agreements.
    American Pharmacists Association Foundation and American Pharmacists Association
    J Am Pharm Assoc (2003); 2013; 53(2):e132-41. PubMed ID: 23571636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Legislation proposes adding pharmacist services to Medicare.
    Thompson CA
    Am J Health Syst Pharm; 2014 Apr; 71(8):606-7. PubMed ID: 24688029
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacist 'provider status' legislation introduced into the Senate.
    Young D
    Am J Health Syst Pharm; 2003 Aug; 60(15):1502. PubMed ID: 12951746
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicare annual wellness visits conducted by a pharmacist in an internal medicine clinic.
    Warshany K; Sherrill CH; Cavanaugh J; Ives TJ; Shilliday BB
    Am J Health Syst Pharm; 2014 Jan; 71(1):44-9. PubMed ID: 24352181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transitional care CPT codes may include pharmacists' services.
    Traynor K
    Am J Health Syst Pharm; 2013 May; 70(9):748, 750. PubMed ID: 23592353
    [No Abstract]   [Full Text] [Related]  

  • 10. Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care.
    McGivney MS; Meyer SM; Duncan-Hewitt W; Hall DL; Goode JV; Smith RB
    J Am Pharm Assoc (2003); 2007; 47(5):620-8. PubMed ID: 17848353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing pharmacist-led annual wellness visits: Interventions made and patient and physician satisfaction.
    Wilson CG; Park I; Sutherland SE; Ray L
    J Am Pharm Assoc (2003); 2015; 55(4):449-54. PubMed ID: 26161489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of pharmacists in the evolution of health care: an open forum discussion.
    Kelly HW
    Pharmacotherapy; 2006 Sep; 26(9 Pt 2):200S-2S. PubMed ID: 16945067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of consultant pharmacist in subacute care.
    Tedesco P; Fantasia J
    Med Interface; 1997 Mar; 10(3):90-2. PubMed ID: 10166043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacists need recognition as providers to enhance patient care.
    White CM
    Ann Pharmacother; 2014 Feb; 48(2):268-73. PubMed ID: 24259647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
    Wang J; Hong SH; Meng S; Brown LM
    Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
    Skelton JB; ;
    J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical services in hospices.
    Berry JI; Pulliam CC; Caiola SM; Eckel FM
    Am J Hosp Pharm; 1981 Jul; 38(7):1010-4. PubMed ID: 7258198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential impact of pharmacist interventions to reduce cost for Medicare Part D beneficiaries.
    Thatcher EE; Vanwert EM; Erickson SR
    J Pharm Pract; 2013 Jun; 26(3):248-52. PubMed ID: 23178417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bipartisan, bicameral bill would add pharmacist services to Medicare.
    Thompson CA
    Am J Health Syst Pharm; 2015 Mar; 72(6):426-7. PubMed ID: 25736931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.